secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0000950170-25-085364
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology stockholders elect directors, approve advisory pay vote, ratify KPMG
--------------------------------------------------------------------------------

- Scott Garland (23.6M for) and Barbara Klencke (30.8M for) elected as Class II directors to serve until 2028 annual meeting.
- Advisory vote on named executive officer compensation approved: 22.1M for, 8.7M against, 1.4M abstain.
- KPMG LLP ratified as independent auditor for fiscal year 2025: 41.8M for, 0.06M against, 2.2M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000095017025085364/0000950170-25-085364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000095017025085364/alxo-20250611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-085364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer